Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

Data as of Sep 19
 +0.02 / +0.14%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products mainly target therapeutic fields such as transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. Its global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Contact Information

Astellas Pharma, Inc.
2-3-11 Nihonbashi-Honcho
Tokyo Tokyo 103-8411
P:(133) 244-3000
Investor Relations:
(133) 244-3271



Other institutional0.06%
Mutual fund holders0.01%
Individual stakeholders--

Top Executives

Yoshihiko HatanakaPresident, CEO & Representative Director
Yasumasa MasudaSenior Executive Officer & Head-Finance
Sef KurstjensChief Medical Officer
Mitsunori MatsudaExecutive Officer & General Manager-Technology
Shinichi TsukamotoSenior Executive Officer & GM-Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.